高级检索
安方玉, 刘雪松, 颜春鲁, 骆亚莉, 刘永琦, 史旭锋, 刘兴吉. 黄芪总皂苷对H22荷瘤小鼠肿瘤抑制作用及机制[J]. 中国公共卫生, 2017, 33(4): 596-598. DOI: 10.11847/zgggws2017-33-04-20
引用本文: 安方玉, 刘雪松, 颜春鲁, 骆亚莉, 刘永琦, 史旭锋, 刘兴吉. 黄芪总皂苷对H22荷瘤小鼠肿瘤抑制作用及机制[J]. 中国公共卫生, 2017, 33(4): 596-598. DOI: 10.11847/zgggws2017-33-04-20
AN Fang-yu, LIU Xue-song, YAN Chun-lu.et al, . Inhibitive effect of total astragalus saponin on tumor and its mechanism in H22-bearing mice[J]. Chinese Journal of Public Health, 2017, 33(4): 596-598. DOI: 10.11847/zgggws2017-33-04-20
Citation: AN Fang-yu, LIU Xue-song, YAN Chun-lu.et al, . Inhibitive effect of total astragalus saponin on tumor and its mechanism in H22-bearing mice[J]. Chinese Journal of Public Health, 2017, 33(4): 596-598. DOI: 10.11847/zgggws2017-33-04-20

黄芪总皂苷对H22荷瘤小鼠肿瘤抑制作用及机制

Inhibitive effect of total astragalus saponin on tumor and its mechanism in H22-bearing mice

  • 摘要: 目的 探讨黄芪总皂苷对小鼠肝癌H22肿瘤生长及免疫功能影响。方法 建立小鼠肝癌H22移植瘤模型,小鼠随机分为对照组、模型组、黄芪总皂苷高、中、低剂量组;称重法检测小鼠抑瘤率、脾脏指数、胸腺指数;噻唑蓝法检测小鼠淋巴细胞增殖能力及T淋巴细胞转化能力,酶联免疫法检测小鼠血清中白细胞介素-2(IL-2)含量。结果 与对照组比较,模型组小鼠体重(24.90±2.82)g明显减轻,胸腺、脾脏指数分别为(1.47±0.45)、(3.97±0.05)mg/g明显下降,淋巴细胞增殖能力(0.10±0.02)及转化能力(1.08±0.03)%明显降低,血清IL-2含量(87.59±28.60)pg/mL明显下降(P<0.05);与模型组比较,黄芪总皂苷各剂量组小鼠肿瘤生长均明显受到抑制,黄芪总皂苷低、中、高剂量组小鼠胸腺与脾脏指数分别为(2.18±0.34/)、(2.47±0.54/)、(2.51±0.46/) 与(5.42±0.84)、(6.13±0.71)、(6.46±0.85)mg/g升高,淋巴细胞增殖能力分别为(0.17±0.01)、(0.18±0.03)、(0.19±0.01) 和T淋巴细胞转化能力分别为(1.14±0.07)、(1.15±0.06)、(1.20±0.07)%增强,血清IL-2含量分别为(117.67±30.28)、(121.80±34.04)、(124.93±37.10)pg/mL升高。结论 黄芪总皂苷可抑制小鼠肝癌H22肿瘤细胞的增殖,其机制可能与增强机体的免疫功能有关。

     

    Abstract: Objective To investigate the effect of different concentration of total astragalus saponin on the growth of tumor cells and immune function in H22-bearing mice.Methods The H22 liver tumor model was established and the H22-bearing mice were randomly divided into a tumor bearing model group,low-,medium-,and high-dose total astragalus saponin treatment groups;a control group was also set.At the end of 10 day's treatment,tumor inhibition ratio,spleen index,and thymus index of all the mice were determined with weighing method;multiplication capacity of lymphocytes and the transformation ability of T lymphocytes were tested with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay;meanwhile,interleukin-2 (IL-2) content was detected with enzyme-linked immunosorbent assay (ELISA).Results Compared with those in the control group,the body weight (24.90±2.82 g),thymus index (1.47±0.45 mg/g),and spleen index (3.97±0.05 mg/g) decreased significantly in the model group (P<0.05 for all); the lymphocyte multiplication capacity (0.10±0.02) and the T lymphocyte transformation ability (1.08±0.03) declined obviously in the model group (both P<0.01);the IL-2 content (87.59±28.60 pg/ml) was significantly down-regulated in the model group (P<0.01).Compared to that in the model group,the growth of tumor in total astragalus saponin treatment groups was obvious inhibited (P<0.01).For the mice of low-,medium-,and high-dose total astragalus saponin treatment groups,the thymus index (2.18±0.34,2.47±0.54,and 2.51±0.46 mg/g),the spleen index (1.14±0.07,6.13±0.71,and 6.46±0.85 mg/g),the capacity of lymphocyte multiplication (0.17±0.01,0.18±0.03,and 0.19±0.01),the lymphocyte transformation (5.42±0.84,1.15±0.06,and 1.20±0.07),and the content of IL-2 (117.67±30.28,121.80±34.04,and 124.93±37.10 pg/ml) were all higher than those of the model group.Conclusion The total astragalus saponin could inhibit the proliferation of tumor cells in H22-bearing mice and the mechanism of the inhibitive effect may be related to increased immune function.

     

/

返回文章
返回